| Safety and Efficacy of HMI-103 in Participants With Classical PKU Due to PAH Deficiency (NCT05222178) | Homology Medicines, Inc | 2022-06-03 |
| Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU (NCT05356377) | University of Missouri-Columbia | 2022-05-25 |
| Evaluation of PKU Explore France (NCT04898829) | Vitaflo International, Ltd | 2022-05-18 |
| Study to Evaluate the Effect on Nitrogen Retention of Two Different Posology Schemes of PKU GOLIKE PLUS 3-16 and Free AAs in Patients With Phenylketonuria (NCT05229549) | APR Applied Pharma Research s.a. | 2022-05-06 |
| Life With Phenylketonuria. Adult Neurological Outcome of PCU Screened Patients From 1971 to 2002. (NCT04433728) | University Hospital, Lille | 2021-12-17 |
| The Effect of Nursing Empowerment Program (NCT05497050) | Cukurova University | 2021-11-24 |
| Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference? (NCT05128149) | University Children's Hospital, Zurich | 2021-11-15 |
| Comparison of Atherogenic Risk Factors and Efficacy of Nutritional Treatment Among Adult Phenylketonuria Patients (NCT04969809) | University Medical Centre Ljubljana | 2021-09-01 |
| Evaluation of the Express Plus Range (NCT05051657) | Vitaflo International, Ltd | 2021-06-14 |
| Natural History Clinical Study in Adult PKU (NCT04768348) | Homology Medicines, Inc | 2021-04-20 |
| Acceptability and Tolerance of a Ready-to-use Protein Substitute in Tablet Form for the Dietary Management of Phenylketonuria (NCT04375592) | metaX Institut fuer Diatetik GmbH | 2021-02-01 |
| Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CDX 6114 in PKU Patients (NCT04256655) | Société des Produits Nestlé (SPN) | 2020-12-01 |
| Remote Neurocognitive and Psychological Assessment in PKU (NCT04943393) | University of Missouri-Columbia | 2020-11-24 |
| Evaluation of PKU Sphere in Italy (NCT04679467) | Vitaflo International, Ltd | 2020-08-10 |
| Early Dietary Treated Patients With Phenylketonuria Can Achieve Normal Growth and Mental Development. (NCT04302194) | Assiut University | 2020-05-01 |
| Safety and Tolerability of RTX-134 in Adults With Phenylketonuria (NCT04110496) | Rubius Therapeutics | 2020-01-29 |
| Short-term Effects of Good Metabolic Control on Cognitive Function, Wellbeing, and Metabolic Parameters in Adult Patients With Phenylketonuria (NCT04210206) | Klaus Parhofer | 2019-12-01 |
| A Prospective Clinical Study of Phenylketonuria (PKU) (NCT04452513) | BioMarin Pharmaceutical | 2019-10-11 |
| Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU) (NCT04404530) | Emory University | 2019-10-08 |
| Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism (NCT04248062) | University Children's Hospital, Zurich | 2019-08-01 |
| Impact of Fruit and Vegetables in PKU (NCT05249218) | Alex Pinto | 2019-07-20 |
| Compliance, Tolerance and Acceptability of a Tablet Protein Substitute for the Dietary Management of Phenylketonuria (NCT03333720) | Nutricia UK Ltd | 2019-07-15 |
| Effects of Synergy on Nutrient Intake and Acceptability in Phenylketonuria (PKU) (NCT03777826) | Nutricia Research | 2019-06-26 |
| Gene Therapy Clinical Study in Adult PKU (NCT03952156) | Homology Medicines, Inc | 2019-06-10 |
| The Effects of CGMP in Children and Adults With PKU (NCT04076176) | Vitaflo International, Ltd | 2019-04-26 |
| A Study Into the Future Cardiovascular Disease (CVD) Risk of Phenylketonuria (PKU) Patients on a Low Phenylalanine Treatment Diet (LPD). (NCT04251494) | Guy's and St Thomas' NHS Foundation Trust | 2019-02-23 |
| Market Research - Acceptability Study for a New PKU Protein Substitute (NCT04318509) | Dr. Schär AG / SPA | 2019-02-04 |
| Nutrition Status of Adults Treated With Pegvaliase (NCT03792451) | Boston Children's Hospital | 2019-01-17 |
| Nutritional Status in Phenylketonuria (NCT03820804) | Universidade do Porto | 2019-01-07 |
| A 16 Week Study Evaluating the Introduction of a GMP Based Protein Substitute in Participants With PKU (NCT03771391) | Vitaflo International, Ltd | 2018-12-06 |
| Early Check: Expanded Screening in Newborns (NCT03655223) | RTI International | 2018-10-15 |
| Market Research - Acceptability Trial for a New PKU Amino Acid Based Protein Substitute (NCT04309331) | Dr. Schär AG / SPA | 2018-07-01 |
| Evaluation of PKU Sphere (NCT03419819) | Vitaflo International, Ltd | 2018-05-01 |
| Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia (NCT03167697) | Nutricia UK Ltd | 2017-05-01 |
| PKU Skin Stripping (NCT04368624) | Children's Hospital Medical Center, Cincinnati | 2015-10-12 |
| Testing of Four Home Phenylalanine Monitoring Prototype Devices (NCT02445521) | Emory University | 2015-05-01 |
| Bone Mineral Density in Adults With Hyperphenylalaninemia (NCT01209819) | The University of Texas Health Science Center, Houston | 2010-09-01 |
| Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet (NCT00272792) | BioMarin Pharmaceutical | 2006-02-01 |
| A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels (NCT00225615) | BioMarin Pharmaceutical | 2005-11-01 |
| Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels (NCT00104247) | BioMarin Pharmaceutical | 2005-03-01 |
| Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria (NCT00104260) | BioMarin Pharmaceutical | 2004-12-01 |